cc: Life Science Podcast

Buy both of these Limited Availability recordings for a penny! and I’ll send you two more interviews with outstanding life science marketers every month! If you aren’t happy with what I send, well it’s actually free ;-) This double box set includes 2 individual winners from the 2022 SAMPS Awards , presented at Neuroscience in December. Olivier (Ollie) Welaratne is the General Manager at Red Box Di...

I talked to Jason Scharf about new business models and digital health to get a glimpse of where the world of life science and healthcare are going. Jason is the host of the Austin Next Podcast . He has been an operator at companies like Illumina and Keen Health. Below is a taste of the topics we discussed. It seems timely to start with a discussion about business models for anti-infectives - thera...

Developing a new product for launch involves a lot of effort and expense. To maximize your return, it’s important to know 1.) the size of the market for your offering to determine your potential return and 2.) how to prioritize your target customers for a successful launch to build momentum. From your addressable market, how do you find the early adopters? I had a fun conversation with Mehdi Farza...

I’ve been thinking a bit lately about preventative health. We focus a lot in this podcast on therapeutics, some of which I’m personally grateful for. We should keep developing new ones to help people live longer and healthier. But that seems a never-ending game. I don’t see curing all diseases as realistic, nor the only strategy when many diseases can be avoided by changes in behavior. Paying for...

Everyone wants to be patient-centric these days. Betsy Bennett is a health psychologist and behavior change strategist. And, as you’ll discover in this episode, she has been a patient with a serious disease- twice. She has some thoughts about how companies can be helpful to patients over the course of their illness. There are so many good nuggets in this conversation, I’ll summarize a few of them...

Designing new compounds to be used as therapeutics is a challenge regardless of the approach. Artificial intelligence shows promise for solving some of those challenges, whether it’s identifying a hit, lead optimization or something else. Ashwini Ghogare is the intrapreneur CEO of Artificial Intelligence and Automation in Drug Discovery at Millipore Sigma. She was kind enough (and patient enough)...

While launching a new product is exciting, especially in the sciences, it’s not the only way to grow a business. We can change our business models or how we go to market. Dave Brock shared with me some of the things that he has seen in terms of companies thinking more broadly about how to do things. There is typically a cycle that companies go through. First is, “How do we do more?” A volume and v...

Your company runs on information to a large degree. But not all of it is accessible to the people who need to make decisions which slows things down, making you less competitive. Seth Earley is the CEO of Earley Information Science. We had a conversation about using artificial intelligence to make information flow faster within companies. The key concept was the use of ontologies in the informatio...

Can you really make serious progress with an intern? The answer is a definite yes and it can work out for the intern, the host company and a vendor. Bob Lempke is the Chief Commercial Officer at Mobile Locker. He’s been on the podcast before. On a catch-up call, he told me this great story about working with an intern at one of their customers, Allergan Aesthetics, and AbbVie company. Sunethra Kan...

Erica Sosnowski, the Managing Partner at Sosna + Co. recently posted on LinkedIn a list of things that life science executives struggle with the most in the context of finding and executing deals . From her post: - A limited network due to time spent in academia or in the “science” of their business- Lack of understanding (despite best efforts) on how to move your business beyond the small-to-medi...

So you want to be a thought leader? I talked to Brian Morgan, President of Think Deeply, Write Clearly about effective thought leadership communication. Thought leadership can be used to attract an audience who may need your product or service. Or you may want to influence decision-making in a particular direction. You can see the overlap with content marketing. In our conversation, Brian brought...

PharmExec.com published a study in 2020 of 25 first commercial launches. 48% of them missed their first year forecast for sales ( 130% of forecast). Outperformers started commercial planning more than 2 years ahead of approval and typically spent more on SG&A. It has to be difficult for a CEO or CFO to devote resources to commercializing a therapy when approval is still uncertain and far away. I i...

Paul Simms describes himself as a noisy introvert. Does that mean he’s a troublemaker? He’s definitely trying to stir things up in the pharma/ life science world as CEO of Impatient Health . You should take a look at his blog to get an idea of what he’s up to. I wanted to talk about some things I saw there and on LinkedIn. The world for the last fifty (seventy?) years has been pretty predictable....

Kristin Apple is the President of LINUS. We talked about the future of healthcare specifically for seniors 60-79 and how they think about it based on a recent survey (Link below). This is worth paying attention to because this age group is the fastest growing segment of the population. How they think about aging and what innovators can do to meet the needs of this group represents a big opportunit...

I saw this LinkedIn post from Erasmus Holm, Chief Marketing Officer for the Nordics at MSD, and was curious to learn more. He mentions that the pandemic, although demanding a lot of change, hasn’t necessarily had the lasting effect we expected. He sees companies reverting to the old ways of doing things. I asked him about how he sees digital transformation, a term I hear a lot, but whose definitio...

One of my goals for this podcast series is to cover the use of AI in everything from drug development to the clinic. This episode sits at the trailhead for that journey. I met Nicolas Tilmans , Founder of Anagenex on Twitter. Anagenex is “building a directed evolution platform to develop new small molecules by combining massively parallel biochemical experiments and machine learning.” Specifically...

This week I talked to Don Davis of 5280 Life Sciences Consulting. Don helps companies scale up through leadership development, project and process improvements. He is also the host of the Life Science Success podcast. The challenge comes when a small company of about ten employees becomes successful and gets an influx of cash and all of a sudden is becoming a company of one or two hundred. Interes...

What is the path to success in sales when you are selling both direct and through a distributor? What is the best approach for you and your company? Even though it’s sales, I think it looks a lot like marketing based on my conversation with Drew Hamilton. He is the Southeast regional manager at VistaLab technologies. He is playing the long game by building relationships with his reps (he has 200 f...

Darcy Bevalacqua is a career coach and executive recruiter for senior marketing executives over 50. Nevertheless, this episode has good advice for anyone looking to change jobs and even companies that are competing for talent. Challenges for companies I asked Darcy about the state of the job market. Companies are having a hard time attracting talent right now. She verified what I have seen a lot o...

This episode is not about strategy or tactics or building your marketing team, This week, it's about capabilities. We're going way back to basics, to do a mindset reset on what marketing actually means. How can marketers know their customers better than they know themselves and solve problems for those customers all along their journey, not just with the products or services they sell? Michele Ben...

I met Charles Baldridge, CEO of Sol Analytica on a Zoom call. In an eclectic group of filmmakers, artists, music publishers (and data scientists), Charles mentioned that his company helps others with their data strategy. That set off my curiosity and I invited him to this podcast. I hadn’t really thought about data strategy and didn’t know what it was, but it certainly sounded like something many...

Machines have been helping us with physical work for a long time. Now with AI, machines are helping with the knowledge work. At the outset, AI was working with numbers. Now it’s working with images, words and language. And I’m discovering it’s everywhere with still great potential ahead. Sidd Bhattacharya, Director of Healthcare Analytics and Artificial Intelligence at PWC gave me a lesson on the...

Failure 66% of AI projects fail. That’s the bad news. The good news is that in life science we’re not really investing enough or working on the important problems yet. The opportunities are still there. So we’ve got that going for us. Severence McLaughlin is the CEO of DeLorean Artificial Intelligence. He has some thoughts about what is actually AI, how it’s being deployed, and the impact it could...

Susanna Harris talks about her communications role in the biotech venture capital world. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com

Color Science and Digital Imaging I don't think many people paid too much attention to the sort of miracle that produces color technology in a digital device, because we were so used to using color film, which itself is a technological masterpiece to balance the various photo-sensitive pigments that would result in images that we perceive with our human visual system to look the same as the scene...